Video
Learn how Benchling is powering the next generation of antibody R&D
Informa and Benchling discuss why antibody therapeutics are on the rise, and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.
The video covers:
The growing focus on the next generation of immunotherapies
The challenges that these evolving trends pose for immunotherapy and antibody research
How Benchling is helping companies transform their data management
Join over 200,000 scientists using Benchling to power their biotech R&D
